Cirrhosis: new research provides a basis for rational and targeted treatments
摘要：
Fibrosis, the liver's wound healing response, is bi-directional and potentially reversible. Antiviral treatments provide increasing evidence for reversibility of fibrosis and cirrhosis. Excess fibrillar (scar) matrix can be degraded even in advanced cirrhosis but is held in check by protease inhibitors termed TEMPs. Antifibrotic treatments are likely to be developed in the next decade, on the basis of a better understanding of the pathogenesis of fibrosis. Hepatic stellate cells have been shown to contribute to portal hypertension by dynamic contractile activity; this could lead to the design of specific agents to reduce portal hypertension.
展开
关键词：
Humans Hypertension, Portal Tissue Inhibitor of Metalloproteinases Biological Markers Liver Cirrhosis Cytokines Recovery of Function Matrix Metalloproteinases
DOI：
10.1136/bmj.327.7407.143
被引量：
年份：
2003
国家科技图书文献中心
(权威机构)
BMJ
掌桥科研
万方医学
Semantic Scholar
查看更多
dx.doi.org
NCBI
(全网免费下载)
Europe PMC
JSTOR
Europe PMC
(全网免费下载)
NCBI
ProQuest
ResearchGate
EBSCO
EBSCO
research.ed.ac.uk
(全网免费下载)
core.ac.uk
iv.iiarjournals.org
mysciencework.com
211.103.242.133:8080
(全网免费下载)
research.ed.ac.uk
eprints.soton.ac.uk
scindeks.ceon.rs
pubget.com
scienceopen.com
mendeley.com
gastrojournal.org
onAcademic
jnl-bmj-d7.drupal-dev-bmj.highwire.org
journal-of-hepatology.eu
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
